{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:58:52Z","timestamp":1794020332369,"version":"4.8.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000785","name":"Education, Audiovisual and Culture Executive Agency","doi-asserted-by":"publisher","award":["Phoenix Erasmus Mundus PhD Fellowship"],"award-info":[{"award-number":["Phoenix Erasmus Mundus PhD Fellowship"]}],"id":[{"id":"10.13039\/501100000785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Care Anal"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The diagnosis of idiopathic short stature (ISS) refers to children who are considerably shorter than average without any identified medical reason. The US Food and Drug Administration (FDA) authorised marketing of recombinant human growth hormone (hGH) for ISS in 2003, while the European Medicines Agency (EMA) refused it in 2007. This paper examines the arguments for these decisions as detailed in selected FDA and EMA documents. It combines argumentative analysis with an approach to policy analysis called \u2018What\u2019s the problem represented to be\u2019. It argues that the FDA presents its approval as an argument for equity of access to the treatment (given that hGH was already authorised for other indications), describing short stature as a potential disadvantage, and assuming that height normalisation is a clinically meaningful result. The EMA, instead, refuses marketing authorisation with an argument that there is an imbalance of risks and benefits, describing ISS as a healthy condition, and arguing that hGH should provide some psychosocial and\/or quality of life benefits to children with ISS other than height gain. This paper then discusses how these arguments could be read through different models of disability, particularly through the medical model of disability and the relational, experiential, and cultural understandings of disability.<\/jats:p>","DOI":"10.1007\/s10728-020-00390-1","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T08:02:58Z","timestamp":1581580978000},"page":"266-282","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A Disability Bioethics Reading of the FDA and EMA Evaluations on the Marketing Authorisation of Growth Hormone for Idiopathic Short Stature Children"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3018-7411","authenticated-orcid":false,"given":"Maria Cristina","family":"Murano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,13]]},"reference":[{"key":"390_CR1","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jpeds.2004.02.028","volume":"144","author":"DB Allen","year":"2004","unstructured":"Allen, D. B., & Fost, N. (2004). HGH for short stature: Ethical issues raised by expanded access. The Journal of Pediatrics,144, 648\u2013652.","journal-title":"The Journal of Pediatrics"},{"key":"390_CR2","volume-title":"Analysing policy: What\u2019s the problem represented to be?","author":"C Bacchi","year":"2009","unstructured":"Bacchi, C. (2009). Analysing policy: What\u2019s the problem represented to be?. Frenchs Forest: Pearson Education."},{"key":"390_CR3","first-page":"1","volume-title":"Problematizations in health policy: Questioning how \u201cproblems\u201d are constituted in policies","author":"C Bacchi","year":"2016","unstructured":"Bacchi, C. (2016). Problematizations in health policy: Questioning how \u201cproblems\u201d are constituted in policies (pp. 1\u201316). London: SAGE Open."},{"key":"390_CR4","doi-asserted-by":"publisher","DOI":"10.1057\/978-1-137-52546-8","volume-title":"Poststructural policy analysis. A guide to practice","author":"C Bacchi","year":"2016","unstructured":"Bacchi, C., & Goodwin, S. (2016). Poststructural policy analysis. A guide to practice. New York: Palgrave Mcmillan."},{"issue":"6","key":"390_CR5","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3201\/eid1806.120116","volume":"18","author":"P Brown","year":"2012","unstructured":"Brown, P., Brandel, J.-P., Sato, T., Nakamura, Y., MacKenzie, J., Will, R. G., et al. (2012). Emerging infectious iatrogenic Creutzfeldt\u2013Jakob disease, final assessment. Emerging Infectious Diseases,18(6), 901\u2013907.","journal-title":"Emerging Infectious Diseases"},{"issue":"11","key":"390_CR6","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1210\/jc.2008-0509","volume":"93","author":"P Cohen","year":"2008","unstructured":"Cohen, P., Rogol, A. D., Deal, C. L., Saenger, P., Reiter, E. O., Ross, J. L., et al. (2008). Consensus statement on the diagnosis and treatment of children with idiopathic short stature: A summary of the growth hormone research society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. Journal of Clinical Endocrinology and Metabolism,93(11), 4210\u20134217.","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"390_CR7","doi-asserted-by":"publisher","DOI":"10.1057\/s41285-019-00113-0","author":"C DeKock","year":"2019","unstructured":"DeKock, C. (2019). Cultural competence and derivatives in substance use treatment for migrants and ethnic minorities: What\u2019s the problem represented to be? Social Theory & Health. https:\/\/doi.org\/10.1057\/s41285-019-00113-0.","journal-title":"Social Theory & Health"},{"key":"390_CR8","unstructured":"European Medicines Agency. (2007). EMEA\/H\/C315\/II\/24. Rapporteurs\u2019 Type II variation 3rd Response Assessment Report NutropinAq (Somatropin), January 2019."},{"key":"390_CR9","unstructured":"European Medicines Agency. (2007). Doc. Ref: EMEA\/137817\/2007\u2014Minutes from the CHMP Scientific Advisory Group Diabetes\/Endocrinology (SAG D\/E) Meeting for Nutropin AQ (somatropin)\u2014EMEA\/H\/C\/315\/II\/24."},{"key":"390_CR10","unstructured":"European Medicines Agency. (2007). Doc. Ref: EMEA\/423515\/2007\u2014Questions and Answers on Recommendation for the Refusal of a Change to The Marketing Authorisation For NutropinAq 2007, January 2019. https:\/\/www.ema.europa.eu\/documents\/smop\/questions-answers-recommendation-refusal-change-marketing-authorisation-nutropinaq_en.pdf."},{"key":"390_CR11","unstructured":"European Medicines Agency. (2007). EMEA\/CHMP\/405136\/2007. EMEA\/H\/C\/000315\/II\/0024. Opinion of the Committee for medicinal products for human use on a type II variation to the terms of the marketing authorisation for medicinal product, invented name: NutropinAq."},{"key":"390_CR12","unstructured":"European Medicines Agency. (2008). EMEA\/H\/C\/315\/II\/24\u2014Withdrawal Assessment Report for NutropinAq 2008, January 2019. https:\/\/www.ema.europa.eu\/documents\/withdrawal-report\/withdrawal-assessment-report-nutropinaq_en.pdf."},{"key":"390_CR13","unstructured":"European Medicines Agency (EMA) website. Retrieved Jan 2019, from https:\/\/www.ema.europa.eu\/en\/about-us\/how-we-work\/european-medicines-regulatory-network."},{"key":"390_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.156.3.230","author":"BS Finkelstein","year":"2002","unstructured":"Finkelstein, B. S., Imperiale, T., & Speroff, T. (2002). Effect of growth hormone therapy on height in children with idiopathic short stature. A meta-analysis. Archives of Pediatric and Adolescent Medicine Journal. https:\/\/doi.org\/10.1001\/archpedi.156.3.230.","journal-title":"Archives of Pediatric and Adolescent Medicine Journal"},{"key":"390_CR15","unstructured":"Food and Drug Administration (FDA) website https:\/\/www.fda.gov\/, last accessed November 2018."},{"key":"390_CR16","unstructured":"Food and Drug Administration. Briefing Document. (2003). Endocrinologic and Metabolic Drugs Advisory Committee June 10, 2003 Humatrope\u00ae (somatropin [rDNA origin] for injection) for Non-Growth Hormone Deficient Short Stature. Volume 1. January 2019: https:\/\/wayback.archive-it.org\/7993\/20170405134939\/https:\/\/www.fda.gov\/ohrms\/dockets\/ac\/03\/briefing\/3957B1_01_Lilly-Humatrope.pdf."},{"key":"390_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4135\/9781412976251.n7","volume-title":"Handbook of disability studies","author":"P Fougeyrollas","year":"2001","unstructured":"Fougeyrollas, P., & Beauregard, L. (2001). Disability: An interactive person-environment social creation. In G. Albrecht, K. Seelman, & M. Bury (Eds.), Handbook of disability studies (pp. 171\u2013194). Thousand Oaks: Sage."},{"key":"390_CR18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11673-012-9380-0","volume":"9","author":"R Garland-Thomson","year":"2012","unstructured":"Garland-Thomson, R. (2012). The case for conserving disability. Bioethical Inquiry,9, 339\u2013355.","journal-title":"Bioethical Inquiry"},{"issue":"2","key":"390_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1353\/ken.2017.0020","volume":"27","author":"R Garland-Thomson","year":"2017","unstructured":"Garland-Thomson, R. (2017). Disability bioethics: From theory to practice. Kennedy Institute of Ethics Journal,27(2), 323\u2013339.","journal-title":"Kennedy Institute of Ethics Journal"},{"issue":"4","key":"390_CR20","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/MOP.0000000000000505","volume":"28","author":"A Grimberg","year":"2017","unstructured":"Grimberg, A., & Allen, D. B. (2017). Growth hormone treatment for growth hormone deficiency and idiopathic short stature: New guidelines shaped by the presence and absence of evidence. Current Opinion in Pediatrics,28(4), 466\u2013471.","journal-title":"Current Opinion in Pediatrics"},{"key":"390_CR21","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1159\/000440804","volume":"84","author":"A Grimberg","year":"2015","unstructured":"Grimberg, A., Cousounis, P., Cucchiara, A. J., Lipman, T. H., & Ginsburg, K. R. (2015). Parental concerns influencing decisions to seek medical care for a child\u2019s short stature. Hormone Research in Paediatrics,84, 338\u2013348.","journal-title":"Hormone Research in Paediatrics"},{"key":"390_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000452150","volume":"86","author":"A Grimberg","year":"2016","unstructured":"Grimberg, A., DiVall, S. A., Polychronakos, C., Allen, D. B., Cohen, L. E., Quintos, J. B., et al. (2016). Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency. Hormone Research in Paediatrics,86, 361\u2013397.","journal-title":"Hormone Research in Paediatrics"},{"key":"390_CR23","unstructured":"Hall, S. (2005). The short of it. The New York Times Magazine. November 2018. https:\/\/www.nytimes.com\/2005\/10\/16\/magazine\/the-short-of-it.html."},{"key":"390_CR24","volume-title":"The argumentative turn in policy analysis reasoning about uncertainty. Logic, Argumentation & Reasoning Series","year":"2016","unstructured":"Hansson, S. O., & Hirsch Hadorn, G. (Eds.). (2016). The argumentative turn in policy analysis reasoning about uncertainty. Logic, Argumentation & Reasoning Series. Cham: Springer."},{"issue":"3","key":"390_CR25","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.17583\/generos.2018.3737","volume":"7","author":"H Hoppstadius","year":"2018","unstructured":"Hoppstadius, H. (2018). What is the problem? Representations of men\u2019s violence against women in a Swedish context. Multidisciplinary Journal of Gender Studies,7(3), 1684\u20131708. https:\/\/doi.org\/10.17583\/generos.2018.3737.","journal-title":"Multidisciplinary Journal of Gender Studies"},{"key":"390_CR26","unstructured":"International Network on the Disability Creation Process. January 2019. https:\/\/ripph.qc.ca\/en\/hdm-dcp-model\/the-model\/."},{"key":"390_CR27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.edurev.2018.04.002","volume":"24","author":"SM Lauritzen","year":"2018","unstructured":"Lauritzen, S. M., & Nodeland, T. S. (2018). \u201cWhat is the problem represented to be?\u201d Two decades of research on Roma and education in Europe. Educational Research Review,24, 148\u2013169.","journal-title":"Educational Research Review"},{"key":"390_CR28","volume-title":"Engaging with Carol Bacchi: Strategic interventions and exchanges","author":"N Marshall","year":"2012","unstructured":"Marshall, N. (2012). Digging deeper: The challenge of problematizing \u201cinclusive development\u201d and \u201cdisability mainstreaming\u201d. In A. Bletsas & C. Beasley (Eds.), Engaging with Carol Bacchi: Strategic interventions and exchanges. Adelaide: University of Adelaide Press."},{"key":"390_CR29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s11019-015-9625-x","volume":"18","author":"KM Martiny","year":"2015","unstructured":"Martiny, K. M. (2015). How to develop a phenomenological model of disability. Medicine, Health Care and Philosophy,18, 553\u2013565.","journal-title":"Medicine, Health Care and Philosophy"},{"key":"390_CR30","unstructured":"Morrison, M. (2008). Beyond Therapy? Investigating biomedical enhancement in the case of human growth hormone. Doctoral thesis, Nottingham University."},{"key":"390_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-230-39244-1","volume-title":"The new politics of disablement","author":"M Oliver","year":"2012","unstructured":"Oliver, M., & Barnes, C. (2012). The new politics of disablement. London: Palgrave Macmillan."},{"key":"390_CR32","first-page":"15","volume-title":"Growth and psyche","author":"DE Sandberg","year":"1999","unstructured":"Sandberg, D. E. (1999). Experiences of being short: Should we expect problems of psychosocial adjustment? In U. Eiholzer, F. Haverkamp, & L. D. Voss (Eds.), Growth and psyche (pp. 15\u201326). Bern: Hogrefe and Huber Publishers."},{"key":"390_CR33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.dhjo.2012.04.002","volume":"5","author":"T Shakespeare","year":"2012","unstructured":"Shakespeare, T. (2012). Commentaries: Developed countries\u2019 responses to the world report on disability. Still a health issue. Disability and Health Journal,5, 129\u2013131.","journal-title":"Disability and Health Journal"},{"key":"390_CR34","doi-asserted-by":"publisher","DOI":"10.4324\/9781315887456","volume-title":"Disability rights and wrongs revisited","author":"T Shakespeare","year":"2013","unstructured":"Shakespeare, T. (2013). Disability rights and wrongs revisited. London: Routledge."},{"key":"390_CR35","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10728-010-0153-9","volume":"19","author":"J Slatman","year":"2011","unstructured":"Slatman, J. (2011). The meaning of body experience evaluation in oncology. Health Care Analysis,19, 295\u2013311.","journal-title":"Health Care Analysis"},{"key":"390_CR36","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s11019-014-9544-2","volume":"17","author":"J Slatman","year":"2014","unstructured":"Slatman, J. (2014). Multiple dimensions of embodiment in medical practices. Medicine, Health Care and Philosophy,17, 549\u2013557.","journal-title":"Medicine, Health Care and Philosophy"},{"key":"390_CR37","volume-title":"The international classification of functioning, disability and health","author":"The World Health Organization (WHO)","year":"2001","unstructured":"The World Health Organization (WHO). (2001). The international classification of functioning, disability and health. Geneva: World Health Organization."},{"key":"390_CR38","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.paid.2016.01.049","volume":"100","author":"JV Valentova","year":"2016","unstructured":"Valentova, J. V., B\u00e1rtov\u00e1, K., \u0160t\u011brbov\u00e1, Z., & Corr\u00eaa Varella, M. A. (2016). Preferred and actual relative height are related to sex, sexual orientation, and dominance: Evidence from Brazil and the Czech Republic. Personality and Individual Differences,100, 145\u2013150.","journal-title":"Personality and Individual Differences"},{"key":"390_CR39","volume-title":"A systematic theory of argumentation. The pragma-dialectical approach","author":"FH Van Eemeren","year":"2004","unstructured":"Van Eemeren, F. H., & Grootendorst, R. (2004). A systematic theory of argumentation. The pragma-dialectical approach. Cambridge: Cambridge University Press."},{"key":"390_CR40","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1136\/bmj.320.7235.612","volume":"320","author":"LD Voss","year":"2000","unstructured":"Voss, L. D., & Mulligan, J. (2000). Bullying in school: are short pupils at risk? Questionnaire study in a cohort. British Medical Journal,320, 612\u2013613.","journal-title":"British Medical Journal"},{"key":"390_CR41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11007-014-9316-y","volume":"48","author":"G Weiss","year":"2015","unstructured":"Weiss, G. (2015). The normal, the natural, and the normative: A Merleau\u2013Pontian legacy to feminist theory, critical race theory, and disability studies. Continental Philosophy Review,48, 77\u201393.","journal-title":"Continental Philosophy Review"},{"issue":"5","key":"390_CR42","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1080\/09687599.2018.1454300","volume":"33","author":"G Yaron","year":"2018","unstructured":"Yaron, G., Meershoek, A., Widdershoven, G., & Slatman, J. (2018). Recognizing difference: In\/visibility in the everyday life of individuals with facial limb absence. Disability & Society,33(5), 743\u2013762.","journal-title":"Disability & Society"}],"container-title":["Health Care Analysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10728-020-00390-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10728-020-00390-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10728-020-00390-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:27:59Z","timestamp":1613089679000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10728-020-00390-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,13]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["390"],"URL":"https:\/\/doi.org\/10.1007\/s10728-020-00390-1","relation":{},"ISSN":["1065-3058","1573-3394"],"issn-type":[{"value":"1065-3058","type":"print"},{"value":"1573-3394","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,13]]},"assertion":[{"value":"13 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The author declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}